Dipeptidyl peptidase IV (DPP-4) inhibition as a treatment for type 2 diabetes

被引：0
|
作者：
Thornberry, Nancy A. [1 ]
机构：
[1] Merck Res Labs, Dept Metab Disosders, Rahway, NJ 07065 USA
来源：
TUMOR BIOLOGY | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [31] Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes
    Xia Wang
    Peilin Zheng
    Gan Huang
    Lin Yang
    Zhiguang Zhou
    [J]. Clinical and Experimental Medicine, 2018, 18 : 473 - 480
  • [32] Sitagliptin: A dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Miller, Shannon A.
    St. Onge, Erin L.
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) : 1336 - 1343
  • [33] Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin
    Taldone, Tony
    Zito, S. William
    Talele, Tanaji T.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) : 479 - 484
  • [34] Effect of a dipeptidyl peptidase 4 (DPP-4) inhibitor, vildagliptin, on gastrointestinal function, nutrient intake and glucose metabolism in type 2 diabetes
    Vella, A.
    Bock, G.
    Giesler, P. D.
    Burton, D. B.
    Foley, J. E.
    Rizza, R. A.
    Camilleri, M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (05): : 434 - 434
  • [35] Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis
    Park, Se Hee
    Nam, Joo Young
    Han, Eugene
    Lee, Yong-ho
    Lee, Byung-Wan
    Kim, Beom Seok
    Cha, Bong-Soo
    Kim, Chul Sik
    Kang, Eun Seok
    [J]. MEDICINE, 2016, 95 (32)
  • [36] Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes
    Lindsay, JR
    Duffy, NA
    McKillop, AM
    Ardill, J
    O'Harte, FPM
    Flatt, PR
    Bell, PM
    [J]. DIABETIC MEDICINE, 2005, 22 (05) : 654 - 657
  • [37] Cardiovascular safety of dipeptidyl peptidase-4 (DPP-4) inhibitors
    Gumprecht, Janusz
    [J]. CLINICAL DIABETOLOGY, 2015, 4 : 19 - 24
  • [38] Cardiovascular safety of dipeptidyl peptidase-4 (DPP-4) inhibitors
    Gumprecht, Janusz
    [J]. CLINICAL DIABETOLOGY, 2015, 4 (06): : 238 - 242
  • [39] Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)
    Thornberry, Nancy A.
    Gallwitz, Baptist
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 479 - 486
  • [40] Dipeptidyl Peptidase-4 (Dpp-4) Inhibitor (Sitagliptin) as a Novel Treatment Agent for Nonalcoholic Fatty Liver Disease Patients With Type 2 Diabetes Mellitus
    Tomeno, Wataru
    Yoneda, Masato
    Imajo, Kento
    Mawatari, Hironori
    Kirikoshi, Hiroyuki
    Saito, Satoru
    Shibata, Wataru
    Yoneda, Kyoko
    Endo, Hiroki
    Kubota, Kensuke
    Nakajima, Atsushi
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S1017 - S1017
12345